Breaking News: The FDA approved a new medication to treat pain from an injury or surgery. Unlike opioid pain medicines, it cannot become addictive.
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
www.nytimes.com
January 30, 2025 at 11:51 PM
Breaking News: The FDA approved a new medication to treat pain from an injury or surgery. Unlike opioid pain medicines, it cannot become addictive.
Ask your doctor today about Journavx.
Side effects, include transparent cranium, see through hair, and x-ray vision.
Side effects, include transparent cranium, see through hair, and x-ray vision.
May 5, 2026 at 1:38 AM
Ask your doctor today about Journavx.
Side effects, include transparent cranium, see through hair, and x-ray vision.
Side effects, include transparent cranium, see through hair, and x-ray vision.
In January, the FDA approved a new non-opioid painkiller.
In today’s episode, we’ll explore the science behind the first new pain medicine in over two decades.
Listen here 🎧: https://buff.ly/40ZyPKh
In today’s episode, we’ll explore the science behind the first new pain medicine in over two decades.
Listen here 🎧: https://buff.ly/40ZyPKh
February 17, 2025 at 7:29 PM
In January, the FDA approved a new non-opioid painkiller.
In today’s episode, we’ll explore the science behind the first new pain medicine in over two decades.
Listen here 🎧: https://buff.ly/40ZyPKh
In today’s episode, we’ll explore the science behind the first new pain medicine in over two decades.
Listen here 🎧: https://buff.ly/40ZyPKh
💊💊💊 FDA approves Vertex's Journavx, the first non-opioid pain drug in a new class for moderate to severe acute pain. A historic milestone for pain management.
Journavx (suzetrigine) targets NaV1.8 sodium channels in pain-sensing neurons--proteins that regulate the flow of ions in neurons
Journavx (suzetrigine) targets NaV1.8 sodium channels in pain-sensing neurons--proteins that regulate the flow of ions in neurons
January 31, 2025 at 3:17 PM
💊💊💊 FDA approves Vertex's Journavx, the first non-opioid pain drug in a new class for moderate to severe acute pain. A historic milestone for pain management.
Journavx (suzetrigine) targets NaV1.8 sodium channels in pain-sensing neurons--proteins that regulate the flow of ions in neurons
Journavx (suzetrigine) targets NaV1.8 sodium channels in pain-sensing neurons--proteins that regulate the flow of ions in neurons
The FDA was barred from issuing press releases, w/ the exception of emergency news. Was this approval really an emergency?
When you only release favorable news, that’s called propaganda.
New non-opioid painkiller approved by US health agency www.bbc.com/news/article...
When you only release favorable news, that’s called propaganda.
New non-opioid painkiller approved by US health agency www.bbc.com/news/article...
Vertex: New non-opioid painkiller Journavx approved by US FDA
New drug suzetrigine, known by its brand name Journavx, has been approved to treat moderate to severe pain.
www.bbc.com
February 2, 2025 at 5:36 AM
The FDA was barred from issuing press releases, w/ the exception of emergency news. Was this approval really an emergency?
When you only release favorable news, that’s called propaganda.
New non-opioid painkiller approved by US health agency www.bbc.com/news/article...
When you only release favorable news, that’s called propaganda.
New non-opioid painkiller approved by US health agency www.bbc.com/news/article...
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
Why a new opioid alternative is out of reach for some pain patients
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
n.pr
July 10, 2025 at 6:02 PM
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
The FDA approved $VRTX Vertex Pharma Journavx (suzetrigine) on January 30, 2025, as the first non-opioid pain medication in its class. Journavx is a tablet that treats moderate to severe acute pain in adult.
February 2, 2025 at 6:27 PM
The FDA approved $VRTX Vertex Pharma Journavx (suzetrigine) on January 30, 2025, as the first non-opioid pain medication in its class. Journavx is a tablet that treats moderate to severe acute pain in adult.
it's called journavx because it kills the pain of journalism
www.scientificamerican.com/article/what...
www.scientificamerican.com/article/what...
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment
www.scientificamerican.com
January 31, 2025 at 11:04 PM
it's called journavx because it kills the pain of journalism
www.scientificamerican.com/article/what...
www.scientificamerican.com/article/what...
Journavx just got FDA approval. If it works as it's supposed to, without side-effects, this could be *really* terrific news.
www.nytimes.com/2025/01/30/h...
www.nytimes.com/2025/01/30/h...
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
www.nytimes.com
January 31, 2025 at 12:04 AM
Journavx just got FDA approval. If it works as it's supposed to, without side-effects, this could be *really* terrific news.
www.nytimes.com/2025/01/30/h...
www.nytimes.com/2025/01/30/h...
The FDA recently approved a novel pain medication developed by Vertex, Journavx (suzetrigine)
www.fda.gov/news-events/...
1/n
www.fda.gov/news-events/...
1/n
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.
www.fda.gov
February 22, 2025 at 10:21 AM
The FDA recently approved a novel pain medication developed by Vertex, Journavx (suzetrigine)
www.fda.gov/news-events/...
1/n
www.fda.gov/news-events/...
1/n
In a small piece of bright news: exciting news today for everyone who wishes there were a non-addictive, effective way to treat pain.
The first in a new class of medications was approved by the FDA 🛟🩺🧪
(Nb: The RCTs for approval focused on acute, not chronic, pain.)
www.nytimes.com/2025/01/30/h...
The first in a new class of medications was approved by the FDA 🛟🩺🧪
(Nb: The RCTs for approval focused on acute, not chronic, pain.)
www.nytimes.com/2025/01/30/h...
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
www.nytimes.com
January 31, 2025 at 2:44 AM
In a small piece of bright news: exciting news today for everyone who wishes there were a non-addictive, effective way to treat pain.
The first in a new class of medications was approved by the FDA 🛟🩺🧪
(Nb: The RCTs for approval focused on acute, not chronic, pain.)
www.nytimes.com/2025/01/30/h...
The first in a new class of medications was approved by the FDA 🛟🩺🧪
(Nb: The RCTs for approval focused on acute, not chronic, pain.)
www.nytimes.com/2025/01/30/h...
A new type of pain medication, possibly as effective as opioids but with no addiction mechanism, has been approved by the FDA.
www.scientificamerican.com/article/what...
www.scientificamerican.com/article/what...
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment
www.scientificamerican.com
February 8, 2025 at 1:29 AM
A new type of pain medication, possibly as effective as opioids but with no addiction mechanism, has been approved by the FDA.
www.scientificamerican.com/article/what...
www.scientificamerican.com/article/what...
e vai se fuder que porra de remédio é esse que se chama journavx. nem dá pra falar esse nome.
nome de app de escrita.
nome de app de escrita.
May 4, 2026 at 1:03 AM
e vai se fuder que porra de remédio é esse que se chama journavx. nem dá pra falar esse nome.
nome de app de escrita.
nome de app de escrita.
The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years.
Vertex Pharmaceuticals, which makes the drug, has billed it as an effective alternative to opioids that isn’t addictive.
Vertex Pharmaceuticals, which makes the drug, has billed it as an effective alternative to opioids that isn’t addictive.
FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
www.washingtonpost.com
January 31, 2025 at 5:24 PM
The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years.
Vertex Pharmaceuticals, which makes the drug, has billed it as an effective alternative to opioids that isn’t addictive.
Vertex Pharmaceuticals, which makes the drug, has billed it as an effective alternative to opioids that isn’t addictive.
Wait...we still have an FDA?
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
www.nytimes.com
January 31, 2025 at 12:23 PM
Wait...we still have an FDA?
JOURNAVX is a nonopioid medicine that works in the peripheral nervous system. Non addictive, I was prescribed this for post hip surgery.
Not 1 insurance covers it, so the $600 cost is prohibitive.
I wonder why they won’t cover it?
GREED.
I’m healing y’all!
#Pinks
#Voices4Victory
#DemVoice1
Not 1 insurance covers it, so the $600 cost is prohibitive.
I wonder why they won’t cover it?
GREED.
I’m healing y’all!
#Pinks
#Voices4Victory
#DemVoice1
October 13, 2025 at 9:35 PM
JOURNAVX is a nonopioid medicine that works in the peripheral nervous system. Non addictive, I was prescribed this for post hip surgery.
Not 1 insurance covers it, so the $600 cost is prohibitive.
I wonder why they won’t cover it?
GREED.
I’m healing y’all!
#Pinks
#Voices4Victory
#DemVoice1
Not 1 insurance covers it, so the $600 cost is prohibitive.
I wonder why they won’t cover it?
GREED.
I’m healing y’all!
#Pinks
#Voices4Victory
#DemVoice1
Herdmom update: cervical spine radio frequency ablation last week went sideways. The suffering was unbearable. A new med - specifically for postop neuropathy .. Journavx. It works!
If you have a pain response to surgical procedures, please discuss this with your doctor. Because I am not a doctor.
If you have a pain response to surgical procedures, please discuss this with your doctor. Because I am not a doctor.
August 26, 2026 at 3:58 PM
Herdmom update: cervical spine radio frequency ablation last week went sideways. The suffering was unbearable. A new med - specifically for postop neuropathy .. Journavx. It works!
If you have a pain response to surgical procedures, please discuss this with your doctor. Because I am not a doctor.
If you have a pain response to surgical procedures, please discuss this with your doctor. Because I am not a doctor.
Huge news: FDA approval today for suzetrigine, the first new drug approval for acute (not chronic) pain in decades and, critically, a non-opioid analgesic:
edition.cnn.com/2025/01/30/h...
edition.cnn.com/2025/01/30/h...
FDA approves first new type of pain medication in 25 years | CNN
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
edition.cnn.com
January 31, 2025 at 4:28 AM
Huge news: FDA approval today for suzetrigine, the first new drug approval for acute (not chronic) pain in decades and, critically, a non-opioid analgesic:
edition.cnn.com/2025/01/30/h...
edition.cnn.com/2025/01/30/h...
4/6
Pain: I stayed ahead of it. I took opioids for the first few nights, on top of the rest of my plan, including Journavx. Within days I was sleeping 6 to 7 hours a night and walking. The hardest parts were exhaustion and stiffness. I had zero bruising.
Pain: I stayed ahead of it. I took opioids for the first few nights, on top of the rest of my plan, including Journavx. Within days I was sleeping 6 to 7 hours a night and walking. The hardest parts were exhaustion and stiffness. I had zero bruising.
October 2, 2026 at 12:14 AM
4/6
Pain: I stayed ahead of it. I took opioids for the first few nights, on top of the rest of my plan, including Journavx. Within days I was sleeping 6 to 7 hours a night and walking. The hardest parts were exhaustion and stiffness. I had zero bruising.
Pain: I stayed ahead of it. I took opioids for the first few nights, on top of the rest of my plan, including Journavx. Within days I was sleeping 6 to 7 hours a night and walking. The hardest parts were exhaustion and stiffness. I had zero bruising.
For the first time in years, the FDA has approved a new non-opioid painkiller, Journavx. This could be life-changing for those in pain, offering relief without the risk of addiction.
February 4, 2025 at 10:48 PM
For the first time in years, the FDA has approved a new non-opioid painkiller, Journavx. This could be life-changing for those in pain, offering relief without the risk of addiction.
The FDA has approved Vertex Pharmaceuticals’ Journavx, a non-opioid pain medication designed to reduce the risk of addiction and overdose. It is the first significant alternative to opioids in over two decades.
ground.news/daily-briefi...
ground.news/daily-briefi...
February 1, 2025 at 3:25 AM
The FDA has approved Vertex Pharmaceuticals’ Journavx, a non-opioid pain medication designed to reduce the risk of addiction and overdose. It is the first significant alternative to opioids in over two decades.
ground.news/daily-briefi...
ground.news/daily-briefi...